PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ:MDCO) today announced its financial results for the second quarter and first half of 2015. Clive Meanwell, the company’s Chairman and Chief Executive Officer, stated: “As anticipated, revenue in the second quarter of 2015 fell further as purchasers continued to hold out for the potential arrival of generic Angiomax. Now, with resolution of that uncertainty we have moved on. We have contracted with Sandoz to launch an authorized ge
| < Prev | Next > |
|---|
